(Q38931801)

7 September 2017

title

Effect of microRNA-101 on proliferation and apoptosis of human osteosarcoma cells by targeting mTOR. (English)

1 reference

7 September 2017

0 references

1 reference

Song Lin

1

1 reference

7 September 2017

Nan-nan Shao

2

1 reference

7 September 2017

Lei Fan

3

1 reference

7 September 2017

Xiu-cai Ma

4

1 reference

7 September 2017

Fei-fei Pu

5

1 reference

7 September 2017

Zeng-wu Shao

6

1 reference

7 September 2017

publication date

6 December 2014

1 reference

Journal of Huazhong University of Science and Technology. Medical Sciences

7 September 2017

published in

1 reference

7 September 2017

volume

34

1 reference

7 September 2017

issue

6

1 reference

7 September 2017

page(s)

889-895

1 reference

https://scigraph.springernature.com/pub.10.1007/s11596-014-1369-y

7 September 2017

exact match

0 references

cites work

MicroRNA Involvement in Osteosarcoma

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1369-Y

MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), amplified on chromosome 9, collaborate with p53 deficiency in mouse osteosarcoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1369-Y

The epidemiology of osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1369-Y

microRNAs: tiny regulators with great potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1369-Y

Versatility of MicroRNA biogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1369-Y

MicroRNA-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1369-Y

MicroRNA-145 targets vascular endothelial growth factor and inhibits invasion and metastasis of osteosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1369-Y

MicroRNA-101 suppresses motility of bladder cancer cells by targeting c-Met

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1369-Y

MicroRNA-101 suppresses SOX9-dependent tumorigenicity and promotes favorable prognosis of human hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1369-Y

MiR-101 is involved in human breast carcinogenesis by targeting Stathmin1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1369-Y

Targeting mTOR pathways in human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1369-Y

mTOR expression and prognosis in elderly patients with laryngeal carcinoma: uni- and multivariate analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1369-Y

microRNAs as oncogenes and tumor suppressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1369-Y

OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1369-Y

MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1369-Y

Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1369-Y

MicroRNA-101 (miR-101) post-transcriptionally regulates the expression of EP4 receptor in colon cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1369-Y

MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1369-Y

MicroRNA-101 mediates the suppressive effect of laminar shear stress on mTOR expression in vascular endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1369-Y

mTOR signaling in growth control and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1369-Y

NVP-BEZ235, a dual PI3K/mTOR inhibitor, inhibits osteosarcoma cell proliferation and tumor development in vivo with an improved survival rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1369-Y

Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-014-1369-Y

Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols

21 January 2018

1 reference

12 December 2020

mTOR inhibitor AZD8055 inhibits proliferation and induces apoptosis in laryngeal carcinoma

1 reference

12 December 2020

MicroRNA-101 inhibits cell proliferation, invasion, and promotes apoptosis by regulating cyclooxygenase-2 in Hela cervical carcinoma cells.

1 reference

12 December 2020

Immunohistochemical expression of mTOR negatively correlates with PTEN expression in gastric carcinoma.

1 reference

12 December 2020

miR-101 sensitizes A549 NSCLC cell line to CDDP by activating caspase 3-dependent apoptosis

1 reference

12 December 2020

Osteosarcoma: a review of diagnosis, management, and treatment strategies.

1 reference

12 December 2020

miR-101 inhibits autophagy and enhances cisplatin-induced apoptosis in hepatocellular carcinoma cells

1 reference

12 December 2020

10.1007/S11596-014-1369-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

7 September 2017

1042573780

0 references

1 reference